SCHEMBL2818675

SCHEMBL2818675

CCN1CC(=O)Oc2ccc(C(=O)Cc3ccc(OC)cc3Cl)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
GAA P10253 4/20 0.40
ALDH1A1 P00352 3/20 0.40
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
USP2 O75604 2/20 0.40
ALOX15 P16050 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
TP53 P04637 1/20 0.40
ALOX12 P18054 1/20 0.40
HSD17B10 Q99714 1/20 0.40
LMNA P02545 2/20 0.37
CTNNB1 P35222 2/20 0.36
WNT3A P56704 2/20 0.36
KMT2A Q03164 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
BRD4 O60885 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
P2RX7 Q99572 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL474377 0.89 GAA (0.38) KDM4EGAAALDH1A1POLBMAPT
SCHEMBL474450 0.79 CBX7 (0.49) KDM4EALDH1A1POLBMAPTUSP2
SCHEMBL474428 0.77 CBX7 (0.46) ALDH1A1MAPTUSP2ALOX15HSD17B10
SCHEMBL474700 0.76 KDM4E (0.40) KDM4EGAAALDH1A1POLBMAPT
SCHEMBL474479 0.74 CBX7 (0.46) KDM4EALDH1A1POLBMAPTUSP2
SCHEMBL474597 0.74 CPS1 (0.39) KDM4EHSD17B10LMNANPC1RAB9A
SCHEMBL474465 0.73 CBX7 (0.44) ALDH1A1MAPTALOX15HSD17B10LMNA
SCHEMBL473921 0.71 CDYL2 (0.49) ALDH1A1MAPTLMNAKMT2ANPC1
SCHEMBL474639 0.70 SMN1; SMN2 (0.53) KDM4EALDH1A1POLBMAPTHSD17B10
SCHEMBL474378 0.69 CBX7 (0.46) ALDH1A1MAPTUSP2ALOX15TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130172335-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2013-07-04 US disclosed
US-8450313-B2 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds HOFFMANN-LA ROCHE INC. (US) 2013-05-28 US disclosed
US-8268820-B2 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds HOFFMANN-LA ROCHE INC. (US) 2012-09-18 US disclosed
US-20120232071-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HUNZIKER DANIEL (CH) 2012-09-13 US disclosed
US-20100249124-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130172335-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, MC2R KDM4E 1608/4885GAA 3794/4885ALDH1A1 708/4885
US-20100249124-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, MC2R KDM4E 2537/4885GAA 3857/4885ALDH1A1 725/4885
US-20120232071-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, MC2R KDM4E 1608/4885GAA 3794/4885ALDH1A1 708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.